- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01890369
Modulation of Muscle Protein Metabolism by Essential Amino Acids (Aj1B)
January 16, 2014 updated by: University of Nottingham
The investigators plan to explore the ability of amino acids, the building blocks of proteins in our bodies and in the food we eat, to stimulate muscles to grow and stay strong.
The investigators will investigate how rapidly after one meal the human body is ready to make use of a second meal and look at the molecular mechanisms underlying this.
The investigators will look at these phenomena in older men as this group is known to be subject to a gradual loss of muscle mass and strength.
Study Overview
Status
Unknown
Conditions
Detailed Description
Muscles can stay very constant in size for much of adult life yet dramatic wasting is seen in advanced age and ill health.
A better understanding of how muscles regulate their size will help design treatments to slow wasting in disease and to promote active aging.
We plan to study a group of older men, ~70yrs, the age at which muscle bulk starts to decrease, to observe how the muscles respond to feeding.
We will provide a drink that contains the digested products of proteins from which muscles are built.
Taking blood samples and some tiny biopsies of muscle (done under local anaesthesia) will allow us to measure muscle turnover and we will be able to measure for how long after a meal muscles actively take in nutrients before becoming "full".
We will also measure how long the muscle remains "full" before it returns to a state where it can again be stimulated to take in nutrients.
We will also explore if leucine, one of the component parts of protein (especially in meat and dairy products) and a food widely used supplement, can promote the early re-stimulation of muscle by eating.
Study Type
Interventional
Enrollment (Anticipated)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Derby, United Kingdom, DE22 3DT
- Recruiting
- School of Graduate Entry Medicine
-
Contact:
- William K Mitchell, MA,MB,BChir
- Phone Number: (+44)1332 724681
- Email: kylemitchell@doctors.net.uk
-
Sub-Investigator:
- William K Mitchell, MA MB BChir
-
Principal Investigator:
- Philip J Atherton, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years to 75 years (Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Male
- 65-75yrs
- BMI 18-28
Exclusion Criteria:
- Type 2 Diabetes mellitus
- Neurological Disease
- Significant cardiac, hepatic or renal disease
- Active malignancy
- Medication inc. Corticosteroids, NSAID use, Beta adrenoblockers.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Early leucine refeed
15g Mixed Essential Amino Acids.
90 min delay.
3g Leucine
|
Dissolved in 250ml water.
Dissolved in 250ml water.
|
|
Experimental: Early EAA refeed
15g Mixed Essential Amino Acids.
90 min delay.
15g Mixed Essential Amino Acid REFEED
|
Dissolved in 250ml water.
Dissolved in 250ml water.
|
|
Experimental: Mid latency EAA refeed
15g Mixed Essential Amino Acids.
150 min delay.
15g Mixed Essential Amino Acid REFEED
|
Dissolved in 250ml water.
Dissolved in 250ml water.
|
|
Experimental: Late latency EAA refeed
15g Mixed Essential Amino Acids.
210 min delay.
15g Mixed Essential Amino Acid REFEED
|
Dissolved in 250ml water.
Dissolved in 250ml water.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Myofibrillar Fractional Synthetic Rate
Time Frame: 6-10hrs
|
Assessed by gas-chromatography-combustion-mass spectrometry, using incorporation of a stable isotope tracer (13-C-6 Phe)
|
6-10hrs
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Leg blood flow
Time Frame: 6-10hrs
|
Common femoral bulk flow (Doppler USS)
|
6-10hrs
|
|
mTORC1 and AKT phosphorylation
Time Frame: 6-10hrs
|
Western Immunoblotting
|
6-10hrs
|
|
Muscle Protein Breakdown
Time Frame: 6-10hrs
|
By Arteriovenous limb balance
|
6-10hrs
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Philip J Atherton, PhD, University of Nottingham
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2013
Primary Completion (Anticipated)
June 1, 2014
Study Completion (Anticipated)
July 1, 2014
Study Registration Dates
First Submitted
June 26, 2013
First Submitted That Met QC Criteria
June 28, 2013
First Posted (Estimate)
July 1, 2013
Study Record Updates
Last Update Posted (Estimate)
January 17, 2014
Last Update Submitted That Met QC Criteria
January 16, 2014
Last Verified
January 1, 2014
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- B13122012 GEM BMS
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Old Age
-
Hallym University Kangnam Sacred Heart HospitalCompleted
-
National University of Ireland, Galway, IrelandIrish Research CouncilUnknown
-
University of LisbonAssociacao Protectora dos Diabeticos de PortugalCompleted
-
Second Hospital of Shanxi Medical UniversityCompleted
-
McGill UniversityRéseau québécois de recherche sur le vieillissement; MUHC-Montreal General...Completed
-
Guangzhou Center for Disease Control and PreventionSouthern Medical University, ChinaRecruitingFall | Old AgeChina
-
Riphah International UniversityRecruitingFall | Old AgePakistan
-
Tabula Rasa HealthCareEnrolling by invitation
-
University Hospital, AngersWithdrawnSatisfaction | Old Age | UsabilityFrance
-
The Hong Kong Polytechnic UniversityCompletedOld Age | Family MembersHong Kong
Clinical Trials on 15g Mixed Essential Amino Acids
-
University of NottinghamUnknownOld Age (Focus; Not a Recognized Condition)United Kingdom
-
Texas A&M UniversityRecruiting
-
University of TorontoCompletedHealthy | Increased Metabolic Requirement
-
University of BirminghamUnknown
-
The University of Texas Health Science Center at...National Institute on Aging (NIA)Not yet recruitingChronic Kidney Disease | SarcopeniaUnited States
-
The Swedish School of Sport and Health SciencesRecruitingObesity | Sarcopenia | Aging | Sarcopenic ObesitySweden
-
Jing-yuan Fang, MD, Ph. DShanghai Punan Hospital of Pudong New DistrictNot yet recruiting
-
Arkansas Children's Hospital Research InstituteWithdrawnInsulin Resistance | Body Composition, Beneficial | Liver Steatosis | Whole Body Protein Metabolism
-
Coordinación de Investigación en Salud, MexicoFresenius KabiCompleted
-
University of ArkansasWithdrawn